Nathalie Cartier-Lacave to Female
This is a "connection" page, showing publications Nathalie Cartier-Lacave has written about Female.
Connection Strength
0.070
-
Cartier-Lacave N, Ali R, Yl?-Herttuala S, Kato K, Baetschi B, Lovell-Badge R, Naldini L, Thrasher A. Debate on Germline Gene Editing. Hum Gene Ther Methods. 2016 08; 27(4):135-42.
Score: 0.028
-
Djelti F, Braudeau J, Hudry E, Dhenain M, Varin J, Bi?che I, Marquer C, Chali F, Ayciriex S, Auzeil N, Alves S, Langui D, Potier MC, Laprevote O, Vidaud M, Duyckaerts C, Miles R, Aubourg P, Cartier N. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease. Brain. 2015 Aug; 138(Pt 8):2383-98.
Score: 0.026
-
N?brega C, Mendon?a L, Marcelo A, Lamazi?re A, Tom? S, Despres G, Matos CA, Mechmet F, Langui D, den Dunnen W, de Almeida LP, Cartier N, Alves S. Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia. Acta Neuropathol. 2019 11; 138(5):837-858.
Score: 0.009
-
Audrain M, Fol R, Dutar P, Potier B, Billard JM, Flament J, Alves S, Burlot MA, Dufayet-Chaffaud G, Bemelmans AP, Valette J, Hantraye P, D?glon N, Cartier N, Braudeau J. Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression. Mol Neurodegener. 2016 Jan 12; 11:5.
Score: 0.007